Dose escalation and quality of life in patients with localized prostate cancer treated with radiotherapy: long-term results of the Dutch randomized dose-escalation trial (CKTO 96-10 trial).

No abstract is available for this paper.

• Publication year

  2011

• Venue

  International Journal of Radiation Oncology, Biology, Physics

• Publication date

  2011-03-15

• Fields of study

  Medicine, Physics

• Identifiers
  DOI 10.1016/j.ijrobp.2009.12.039PMID 20421153
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer.

  2008cited by this paper
• Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer.

  2008cited by this paper
• Health-related quality of life in patients with locally advanced prostate cancer after 76 Gy intensity-modulated radiotherapy vs. 70 Gy conformal radiotherapy in a prospective and longitudinal study.

  2007cited by this paper
• Health-related quality-of-life after external beam radiation therapy for localized prostate cancer: intensity-modulated radiation therapy versus conformal radiation therapy

  2007cited by this paper
• Sexual function after three-dimensional conformal radiotherapy for prostate cancer: results from a dose-escalation trial.

  2007cited by this paper
• Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial.

  2005cited by this paper
• Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy.

  2005cited by this paper
• Turning the tide: benefit finding after cancer surgery.

  2004cited by this paper
• SF-36 health survey: Manual and interpretation guide

  2003cited by this paper
• Quality-of-life questionnaire results 2 and 3 years after radiotherapy for prostate cancer in a randomized dose-escalation study.

  2003cited by this paper
• Short-course intensity-modulated radiotherapy (70 GY at 2.5 GY per fraction) for localized prostate cancer: preliminary results on late toxicity and quality of life.

  2001cited by this paper
• SF-36 Health Survey Update

  2000cited by this paper
• Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy.

  1999cited by this paper
• Changes in quality of life following treatment for early prostate cancer.

  1999cited by this paper
• Interpreting the significance of changes in health-related quality-of-life scores.

  1998cited by this paper

• Genetic markers of late radiation toxicity in the era of image-guided radiotherapy: lower toxicity rates reduce the predictive value of γ-H2AX foci decay ratio in patients undergoing pelvic radiotherapy

  2024cites this paper
• Overall Survival and Cancer-Specific Mortality in Patients with Prostate Cancer Undergoing Definitive Therapies: A Narrative Review

  2024cites this paper
• Development of deep learning-based novel auto-segmentation for the prostatic urethra on planning CT images for prostate cancer radiotherapy

  2024cites this paper
• The expanding role of radiation oncology across the prostate cancer continuum

  2024cites this paper
• Harnessing progress in radiotherapy for global cancer control

  2023cites this paper
• Feasibility study of manual dose escalation method with normal tissue complication probability in radiation dose escalation for prostate cancer

  2023cites this paper
• Dose-escalated radiotherapy for clinically localized and locally advanced prostate cancer.

  2023cites this paper
• Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate

  2023cites this paper
• A Comparison between Patient- and Physician-Reported Late Radiation Toxicity in Long-Term Prostate Cancer Survivors

  2022cites this paper
• Introducing new plan evaluation indices for prostate dose painting IMRT plans based on apparent diffusion coefficient images

  2022cites this paper
• Propensity score-matched analysis comparing dose-escalated intensity-modulated radiation therapy versus external beam radiation therapy plus high-dose-rate brachytherapy for localized prostate cancer

  2022cites this paper
• Clinical predictors of severe late urinary toxicity after curative intensity-modulated radiation therapy for localized prostate cancer.

  2021cites this paper
• Digital commons

  2020cites this paper
• Dosimetric evaluation of whole-pelvis radiation therapy of prostate cancers: clinical experience

  2020cites this paper
• Hyprofractionated versus conventionally fractionated radiotherapy for patients with intermediate- or high-risk, localized, prostate cancer: 7-year outcomes from the randomized, multi-centre, open-label, phase 3 HYPRO trial.

  2019cites this paper
• Radiotherapy toxicity

  2019cites this paper
• Ten-year survival after High-Dose-Rate Brachytherapy combined with External Beam Radiation Therapy in high-risk prostate cancer: A comparison with the Norwegian SPCG-7 cohort.

  2019cites this paper
• ASCENDE-RT: An Analysis of Health-Related Quality of Life for a Randomized Trial Comparing Low-Dose-Rate Brachytherapy Boost With Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer.

  2017cites this paper
• The Role of Hypofractionated Radiotherapy in Prostate Cancer

  2017cites this paper
• Long-term patient reported outcomes from a phase III randomized prospective trial of conventional versus hypofractionated radiotherapy for localized prostate cancer

  2017cites this paper
• Dosimetric and Radiobiological Evaluation of Multiparametric MRI-Guided Dose Painting in Radiotherapy of Prostate Cancer

  2017cites this paper
• Acute and Late Adverse Events Associated With Radical Radiation Therapy Prostate Cancer Treatment: A Systematic Review of Clinician and Patient Toxicity Reporting in Randomized Controlled Trials.

  2017cites this paper
• Reimbursement for Prostate Cancer Treatment

  2016cites this paper
• Risk Factors and Time to Occurrence of Genitourinary Toxicity After External Beam Radiotherapy for Prostate Cancer.

  2016cites this paper
• Radiotherapy in prostate cancer : information, quality of life and prostate volume

  2016cites this paper
• Rectal dose to prostate cancer patients treated with proton therapy with or without rectal spacer

  2016cites this paper
• High dose versus conventional dose in external beam radiotherapy of prostate cancer: a meta-analysis of long-term follow-up

  2015cites this paper
• Long-Term Patient-Reported Outcomes From a Phase 3 Randomized Prospective Trial of Conventional Versus Hypofractionated Radiation Therapy for Localized Prostate Cancer.

  2015cites this paper
• A systematic review of randomised controlled trials of radiotherapy for localised prostate cancer.

  2015cites this paper
• Dose Escalation: An Update on Randomised Clinical Trials

  2014cites this paper
• High-dose-rate brachytherapy boost for prostate cancer: rationale and technique

  2014cites this paper
• Comparative efficacy and safety of treatments for localised prostate cancer: an application of network meta-analysis

  2014cites this paper
• Efficacy and toxicity of external-beam radiation therapy for localised prostate cancer: a network meta-analysis

  2014cites this paper
• Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials.

  2014cites this paper
• Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials.

  2014cites this paper
• Late Toxicity and Quality of Life

  2014cites this paper
• Target Volume Definition in Primary Prostate Cancer Radiotherapy

  2014cites this paper
• Targeted radiotherapy with gold nanoparticles: current status and future perspectives.

  2014cites this paper
• La Radioterapia Nel Trattamento Del Carcinoma Della Prostata: Indicazioni, Evoluzione Tecnologica e Approcci Integrati

  2013cites this paper
• External Beam Radiotherapy for Low-Risk Prostate Cancer

  2013cites this paper
• Quality of life after radical radiotherapy for prostate cancer: longitudinal study from a randomised trial of external beam radiotherapy alone or in combination with high dose rate brachytherapy.

  2013cites this paper
• Image guided hypofractionated radiotherapy and quality of life for localized prostate cancer: prospective longitudinal study in 337 patients.

  2013cites this paper
• Dose escalation using ultra-high dose IMRT in intermediate risk prostate cancer without androgen deprivation therapy: preliminary results of toxicity and biochemical control

  2013influential citation
• Prostate cancer: ESMO Consensus Conference Guidelines 2012.

  2013cites this paper
• Single-fraction simulation of relative cell survival in response to uniform versus hypoxia-targeted dose escalation

  2012cites this paper
• Quality-of-life outcomes in high-risk prostate cancer patients treated with helical tomotherapy in a hypofractionated radiation schedule with long-term androgen suppression.

  2012cites this paper
• Dose escalation and quality of life in patients with localized prostate cancer treated with radiotherapy: long-term results of the Dutch randomized dose-escalation trial (CKTO 96-10 Trial)

  2012cites this paper
• Impact of diagnosis and treatment of clinically localized prostate cancer on health‐related quality of life for older Americans

  2012cites this paper
• The Dynamics of Dose Escalation of Radiotherapy for Localized Prostate Cancer

  2010cites this paper
• Open Access Journal of Urology Dovepress Role of Hmg-coa Reductase Inhibitors with Curative Radiotherapy in Men with Prostate Cancer

  year unknowncites this paper
• Comparative efficacy and safety of treatments for localised Comparative efficacy and safety of treatments for localised prostate cancer: an application of network meta-analysis prostate cancer: an application of network meta-analysis

  year unknowncites this paper